Search hospitals > South Carolina > Greenville

Prisma Health Cancer Institute - Faris

Claim this profile
Greenville, South Carolina 29605
Global Leader in Cancer
Global Leader in Breast Cancer
Conducts research for Lung Cancer
Conducts research for Adenocarcinoma
Conducts research for Non-Small Cell Lung Cancer
322 reported clinical trials
8 medical researchers
Photo of Prisma Health Cancer Institute - Faris in GreenvillePhoto of Prisma Health Cancer Institute - Faris in GreenvillePhoto of Prisma Health Cancer Institute - Faris in Greenville

Summary

Prisma Health Cancer Institute - Faris is a medical facility located in Greenville, South Carolina. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Adenocarcinoma, Non-Small Cell Lung Cancer and other specialties. Prisma Health Cancer Institute - Faris is involved with conducting 322 clinical trials across 478 conditions. There are 8 research doctors associated with this hospital, such as Ki Chung, MD, Aniket Saha, Jeffrey K. Giguere, and Michael D. Zurenko.

Area of expertise

1Cancer
Global Leader
Prisma Health Cancer Institute - Faris has run 122 trials for Cancer. Some of their research focus areas include:
Stage IV
Stage III
Stage II
2Breast Cancer
Global Leader
Prisma Health Cancer Institute - Faris has run 56 trials for Breast Cancer. Some of their research focus areas include:
Stage IV
HER2 negative
ER positive

Top PIs

Clinical Trials running at Prisma Health Cancer Institute - Faris

Breast Cancer
Lung Cancer
Cancer
Non-Small Cell Lung Cancer
Colorectal Cancer
Tumors
Bladder Cancer
Oropharyngeal Carcinoma
Rectal Cancer
Colon Cancer
Image of trial facility.

Carvedilol

for Preventing Heart Problems in HER2 Positive Breast Cancer

This study is evaluating whether a drug used to treat high blood pressure and heart failure may help prevent heart damage in patients with breast cancer.
Recruiting2 awards Phase 323 criteria
Image of trial facility.

Shorter Chemo-Immunotherapy Without Anthracyclines

for Breast Cancer

This phase III trial compares the effects of shorter chemotherapy (chemo)-immunotherapy without anthracyclines to usual chemo-immunotherapy for the treatment of early-stage triple negative breast cancer. Paclitaxel is in a class of medications called anti-microtubule agents. It stops cancer cells from growing and dividing and may kill them. Carboplatin is in a class of medications known as platinum-containing compounds. It works in a way similar to the anticancer drug cisplatin, but may be better tolerated than cisplatin. Carboplatin works by killing, stopping or slowing the growth of cancer cells. Cyclophosphamide is in a class of medications called alkylating agents. It works by damaging the cell's deoxyribonucleic acid (DNA) and may kill cancer cells. It may also lower the body's immune response. Docetaxel is in a class of medications called taxanes. It stops cancer cells from growing and dividing and may kill them. Doxorubicin is an anthracycline chemotherapy drug that damages DNA and may kill cancer cells. Pembrolizumab may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Shorter treatment without anthracycline chemotherapy may work the same as the usual anthracycline chemotherapy treatment for early-stage triple negative breast cancer.
Recruiting2 awards Phase 347 criteria
Image of trial facility.

Omitting Radiation Therapy

for Breast Cancer

This study is evaluating whether a type of radiation therapy may help prevent breast cancer from coming back.
Recruiting2 awards Phase 319 criteria

Similar Hospitals nearby

Frequently asked questions

What kind of research happens at Prisma Health Cancer Institute - Faris?
Prisma Health Cancer Institute - Faris is a medical facility located in Greenville, South Carolina. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Adenocarcinoma, Non-Small Cell Lung Cancer and other specialties. Prisma Health Cancer Institute - Faris is involved with conducting 322 clinical trials across 478 conditions. There are 8 research doctors associated with this hospital, such as Ki Chung, MD, Aniket Saha, Jeffrey K. Giguere, and Michael D. Zurenko.
Where is Prisma Health Cancer Institute - Faris located?
The Prisma Health Cancer Institute - Faris Hospital is located at 900 W. Faris Road, Greenville, SC 29605.
Who should I call to ask about financial aid or insurance network?
For financial assistance and insurance inquiries at Prisma Health Cancer Institute–Faris Road: - **Financial Assistance**: Visit the Prisma Health financial assistance page for general information. - **Hospital Patient Accounts**: Call 864-454-9604 or toll-free 1-844-302-8298 for billing and insurance inquiries. - **Physician Practice Patient Billing**: For billing questions, contact 864-797-6980 or toll-free 1-844-644-3160.
What insurance does Prisma Health Cancer Institute - Faris accept?
The Prisma Health Cancer Institute - Faris accepts a range of insurance plans such as Absolute Total Care - Ambetter, Absolute Total Care Medicaid, Aetna, Aetna Medicare, Allwell Medicare - Absolute Total Care, BCBS, BCBS Blue Cross, and UnitedHealthcare. It is recommended to directly contact the providers or facilities within the Institute to confirm the acceptance of specific insurance plans.
What awards or recognition has Prisma Health Cancer Institute - Faris received?
The Prisma Health Cancer Institute - Faris, located in Greenville, South Carolina, has received an $8.2 million award from the National Cancer Institute for outstanding research contributions through the National Cancer Institute Community Oncology Research Program. This institute is dedicated to the protection of human subjects in research, holding a Federalwide Assurance (FWA).